ARVO 2017 meeting

Aflibercept rivals laser for diabetic retinopathyIntravitreal aflibercept worked better than panretinal photocoagulation (PRP) for proliferative diabetic retinopathy (PDR) in a new head-to-head trial, according to researchers.
ARVO 2017 awards in spotlightAs eye and vision researchers gather this month for the 2017 meeting of the Association for Research in Vision and Ophthalmology (ARVO), four members will be recognized for their contributions to ophthalmology and vision research with a 2017 ARVO Achievement Award and lecture.
Researchers, scientists flock to East Coast for ARVO 2017The annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) continues to explore new cities after spending many years in Fort Lauderdale, FL. This year’s installment will be held May 6 to 11 at the Baltimore Convention Center, and will feature the theme “Global Connections in Vision Research,” in recognition of the fact that successful science requires strong global connections--among researchers, across disciplines, and between generations.
ARVO 2017 making global connections in vision researchThough the year is quickly winding down, clinical education opportunities still abound for clinicians and vision researchers via the Association for Research in Vision and Ophthalmology (ARVO). For instance, a one-day public workshop will focus on the newest clinical data on inherited retinal diseases and future clinical trial designs aimed at developing therapies to stem vision loss.